Evaluation of the Pharmacokinetics and Safety of Inaxaplin in Participants With Mild or Moderate Hepatic Impairment
Clinical trial NCT06529796 · COMPLETED
Trial details
- NCT number
- NCT06529796
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-02
- Primary completion
- 2024-12-20
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.